Skip to main content
OpenTrials
Completed

NCT Number: NCT00784212

Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy

This study will evaluate the efficacy of BGG492 in reducing the sensitivity to flashing lights of patients with photosensitive epilepsy, using EEG as a readout.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Photosensitive Epilepsy Brain Diseases Central Nervous System Diseases Epilepsy Epilepsy, Reflex Nervous System Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Novartis Investigator Site, Bielefeld, Germany

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of photosensitive epilepsy

Exclusion criteria

  • inconsistent photoparoxysmal response when stimulated by photic stimulation

Other protocol-defined inclusion/exclusion criteria may apply.

Treatment and study plan

BGG492

Drug

Placebo

Drug

Primary outcomes

  1. Outcome Measure: Photoparoxysmal response (PPR) and standardized photoparoxysmal response (SPR) determined by EEG on all treatment days.

    Time frame: Days 1, 2 and 3

Secondary outcomes

  1. Outcome Measure: Safety and tolerability of BGG492 in patients with photosensitive epilepsy

    Time frame: From Day 1 until Day 33 after treatment start.

Sponsors and collaborators

Lead sponsor

Novartis Pharmaceuticals

Industry

Registry information

Official study title

A Multicenter, Single-blind, Within-subject, Placebo-controlled Proof of Concept Study to Assess the Effect of Single Oral Doses of BGG492 on the Photoparoxysmal EEG Response in Patients With Photosensitive Epilepsy

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Nov 3, 2008
Registry last updated
Sep 23, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.